APHB stock news

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 8) Alcon AG (NYSE: ALC ) BioSig Technologies Inc (NASDAQ: BSGM ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 8) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Aquestive Therapeutics Inc (NASDAQ: AQST )(reacted to first-quarter results) Arbutus Biopharma Corp (NASDAQ: ABUS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Flexion Therapeutics Inc (NASDAQ: FLXN ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Opko Health Inc. (NASDAQ: OPK )(reacted to Q1 results) Osmotica Pharmaceuticals PLC (NASDAQ: OSMT ) Retrophin Inc (NASDAQ: RTRX ) Revance Therapeutics Inc (NASDAQ: RVNC ) Sensus Healthcare Inc (NASDAQ: SRTS ) Stock In Focus Novartis to Buy Dry Eye Disease Drug From Takeda For $3.4B Novartis AG (NYSE: NVS ) announced an agreement with Takeda Pharmaceutical Co Ltd (NYSE: TAK ) to acquire the assets associated with Xildra, chemically lifitefgrast ophthalmic solution, 5 percent worldwide for a $3.4 billion payment upfront and potential milestone payments up to $1.9 billion. Read more

AmpliPhi Biosciences EPS in-line

08:53pm, Monday, 06'th May 2019
Read more
Ampliphi Biosciences Corp (APHB) touched 0.30 on a recent bid indicating that the Tenkan line is still hovering below the Kijun Sen. This represents bearish momentum for the shares. Whether or not the Read more
Zooming in closer on shares of Ampliphi Biosciences Corp (APHB), we have noted that the Plus Directional Indicator is currently above the Minus Directional Indicator. Traders following these indicator Read more
Stellar Biotechnologies Inc. (NASDAQ:SBOT) and AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) compete against each other in the Biotechnology sector. We will compare them and contrast their anal Read more
Sentiment for Ampliphi Biosciences Corp (NASDAQ:TGEN) Ampliphi Biosciences Corp (NASDAQ:TGEN) institutional sentiment decreased to 1.4 in 2018 Q4. Its down -1.60, from 3 in 2018Q3. The ratio fall, as Read more
Since Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) and AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) are part of the Biotechnology industry, they are influenced by compare. The influences particul Read more
AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) and Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) are two firms in the Biotechnology that compete against each other. Below is a comparison of their Read more
Traders might be following the technicals on shares of Ampliphi Biosciences Corp (APHB). after a recent check, we have noticed that the PPOH level is currently below zero. With the PPOH below zero, tr Read more
Clarkston Capital Partners Llc decreased Markel Corp (MKL) stake by 1.74% reported in 2018Q4 SEC filing. Clarkston Capital Partners Llc sold 797 shares as Markel Corp (MKL)’s stock declined 11.55%. Read more
Interested investors might be taking a look at the medium range signals for Ampliphi Biosciences Corp (APHB). The reading from the 40-day commodity channel index is currently Hold. The CCI indicator i Read more
This is therefore a contrasting of the profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation in AmpliPhi Read more
The SuperTrend signal is presently lower than the stock price for Ampliphi Biosciences Corp (APHB). Active traders may be carefully tracking the action to see if the indicator position is pointing to Read more
As Biotechnology companies, AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) and Codexis Inc. (NASDAQ:CDXS) are our subject to compare. And more specifically their institutional ownership, profita Read more
Both AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) and Kala Pharmaceuticals Inc. (NASDAQ:KALA) are Biotechnology companies, competing one another. We will compare their analyst recommendations, Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At